BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 31140865)

  • 21. Natural products and their analogues as efficient anticancer drugs.
    Coseri S
    Mini Rev Med Chem; 2009 May; 9(5):560-71. PubMed ID: 19456286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coumarin derivatives with anticancer activities: An update.
    Song XF; Fan J; Liu L; Liu XF; Gao F
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Review on Chemical Profile of Coumarins and their Therapeutic Role in the Treatment of Cancer.
    Venkata Sairam K; Gurupadayya BM; Chandan RS; Nagesha DK; Vishwanathan B
    Curr Drug Deliv; 2016; 13(2):186-201. PubMed ID: 26135671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural dimers of coumarin, chalcones, and resveratrol and the link between structure and pharmacology.
    Menezes JCJMDS; Diederich MF
    Eur J Med Chem; 2019 Nov; 182():111637. PubMed ID: 31494471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioactive Coumarins from Marine Sources: Origin, Structural Features and Pharmacological Properties.
    Vazquez-Rodriguez S; Matos MJ; Borges F; Uriarte E; Santana L
    Curr Top Med Chem; 2015; 15(17):1755-66. PubMed ID: 25915605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review: Biologically active 3,4-heterocycle-fused coumarins.
    Salehian F; Nadri H; Jalili-Baleh L; Youseftabar-Miri L; Abbas Bukhari SN; Foroumadi A; Tüylü Küçükkilinç T; Sharifzadeh M; Khoobi M
    Eur J Med Chem; 2021 Feb; 212():113034. PubMed ID: 33276991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current developments of coumarin-based anti-cancer agents in medicinal chemistry.
    Emami S; Dadashpour S
    Eur J Med Chem; 2015 Sep; 102():611-30. PubMed ID: 26318068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic Mono/di-halogenated Coumarin Derivatives and Their Anticancer Properties.
    Kasumbwe K; Venugopala KN; Mohanlall V; Odhav B
    Anticancer Agents Med Chem; 2017; 17(2):276-285. PubMed ID: 27671300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
    An R; Hou Z; Li JT; Yu HN; Mou YH; Guo C
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30200625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coumarins scaffolds as COX inhibitors.
    Revankar HM; Bukhari SN; Kumar GB; Qin HL
    Bioorg Chem; 2017 Apr; 71():146-159. PubMed ID: 28222891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coumarin Derivatives as Anticancer Agents for Lung Cancer Therapy: A Review.
    Kumar M; Singla R; Dandriyal J; Jaitak V
    Anticancer Agents Med Chem; 2018; 18(7):964-984. PubMed ID: 29298657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
    Ma CC; Liu ZP
    Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovering the structure-activity relationships of different O-prenylated coumarin derivatives as effective anticancer agents in human cervical cancer cells.
    Maleki EH; Bahrami AR; Sadeghian H; Matin MM
    Toxicol In Vitro; 2020 Mar; 63():104745. PubMed ID: 31830504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coumarin derivatives as potential antitumor agents: Growth inhibition, apoptosis induction and multidrug resistance reverting activity.
    Bisi A; Cappadone C; Rampa A; Farruggia G; Sargenti A; Belluti F; Di Martino RMC; Malucelli E; Meluzzi A; Iotti S; Gobbi S
    Eur J Med Chem; 2017 Feb; 127():577-585. PubMed ID: 28109950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of a novel class of coumarin derivatives.
    Li H; Wang X; Xu G; Zeng L; Cheng K; Gao P; Sun Q; Liao W; Zhang J
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5274-8. PubMed ID: 25304898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic and natural coumarins as potent anticonvulsant agents: A review with structure-activity relationship.
    Keri RS; Budagumpi S; Balappa Somappa S
    J Clin Pharm Ther; 2022 Jul; 47(7):915-931. PubMed ID: 35288962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coumarin-benzimidazole hybrids: A review of developments in medicinal chemistry.
    G AC; Gondru R; Li Y; Banothu J
    Eur J Med Chem; 2022 Jan; 227():113921. PubMed ID: 34715585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Review on Anti-urease Potential of Coumarins.
    Asghar H; Asghar H; Asghar T
    Curr Drug Targets; 2021; 22(17):1926-1943. PubMed ID: 33618646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bis-coumarin Derivatives and Their Biological Activities.
    Ren QC; Gao C; Xu Z; Feng LS; Liu ML; Wu X; Zhao F
    Curr Top Med Chem; 2018; 18(2):101-113. PubMed ID: 29473509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review on natural coumarin lead compounds for their pharmacological activity.
    Venugopala KN; Rashmi V; Odhav B
    Biomed Res Int; 2013; 2013():963248. PubMed ID: 23586066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.